	Spese Di Vendita E Di Amministrazione		Data
Alnylam Pharmaceuticals	USD 262.59M	60.72M	2025-09
Celltrion	KRW 249.98B	16.36B	2025-09
Cspc Pharmaceutical	CNY 1.97B	404.66M	2025-09
Dianthus Therapeutics	USD 8.2M	669K	2025-09
Divis Laboratories Ltd	INR 3.4B	10M	2025-06
Gilead Sciences	USD 1.35B	6M	2025-09
Ionis Pharmaceuticals	USD 86.56M	4.04M	2025-09
Kangmei Pharma	CNY 274.41M	15.05M	2025-09
Knight Therapeutics	CAD 25.48M	119K	2024-09
Laboratorios Farma	EUR 35.32M	2.75M	2025-06
MacroGenics	USD 9.9M	600K	2025-09
Malin Corporation	EUR 1.1M	400K	2024-12
Medical Developments International	AUD 7.03M	5.91M	2025-06
Neuren Pharmaceuticals	AUD 1.24M	1.09M	2025-06
Organigram Holdings	CAD 8.86M	499K	2025-09
Pfizer	USD 3.19B	209M	2025-09
Pharma Mar	EUR 13.7M	983K	2025-09
Qiagen NV	USD 143.11M	5.64M	2025-09
Roche Holding	CHF 7.28B	3.99B	2025-12
Sanofi	EUR 2.75B	455M	2025-12
Sarepta Therapeutics	USD 77.11M	7.22M	2025-09
Sartorius	EUR 218.7M	6.5M	2025-09
Sino Biopharmaceutical	CNY 7.54B	2.23B	2025-06
Takeda	JPY 282.78B	29.23B	2025-12
Tilray	USD 24.85M	1.7M	2025-09
Zz Pientze Pharmaceu	CNY 171.91M	343.2M	2025-09

Tectonic Therapeutic Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.